FRIDAY MARCH 19
Copper Hall
MULTI-TRACERS FOR MOLECULAR PROFILING
08:45
TUMOR MICROENVIROMENT AND CELLULAR ADAPTATION: OPPORTUNITIES
FOR IMAGING
B. Wouters (Canada)
09:15
HOW TO IMAGE? (TRACERS) STATE OF THE ART AND FUTURE DEVELOPMENT
C. Halldin (Sweden)
09:45
HOW TO IMAGE QUANTITATIVELY? STATE OF THE ART AND FUTURE EQUIPMENT
DEVELOPMENT
R. Boellaard (Netherlands)
10:15
DISCUSSION TIME
10.30
COFFEE BREAK
TRANSLATING MOLECULAR IMAGING INTO CLINICAL PRACTICE
11:00
THE EGRF STORY FROM A MOLECULAR POINT OF VIEW
G. Van Dongen (Netherlands)
11:25
TUMOR MICROENVIRONMENT INLCUDING HYPOXIA
E. Aboagye (United Kingdom)
11:50
SIMULATION OF HYPOXIA PET TRACER DYNAMICS BASED ON TUMOUR
TISSUE MICROSECTIONS
D. Mönnich (Germany), D. Thorwarth, E. Troost, J. Kaanders, W. Oyen, M. Alber
12:00
PET-IMAGING OF HYPOXIA USING 89ZR-LABELED CG250-F(AB’)2
B. Hoeben (Netherlands), J. Kaanders, P. Laverman, E. Oosterwijk, W. Oyen, O. Boerman,
J. Bussink
12:10
PRECLINICAL EVALUATION OF [18F]HX4, A NOVEL AND PROMISING HYPOXIA
MARKER FOR PET IMAGING
L. Dubois (Netherlands), N. Lieuwes, M. Janssen, J. Secrest, A. Windhorst, G. van Dongen,
H. Kolb, M. Öllers, J. Zhang, P. Lambin
12:20
TARGETING THE LACTATE TRANSPORTER MCT1 INDUCES A METABOLIC
REARRANGEMENT THAT RADIOSENSITIZES TUMORS
P. Sonveaux (Belgium), F. Végran, M. Dewhirst, O. Feron
12.30
LUNCH - IBA Satellite Symposium
TREATMENT SELECTION
14:30
IMPACT ON DISEASE STAGING BY NEW IMAGING MODALITIES
T. F. Hany (Switzerland)
14:55
TUMOUR BIOLOGY-GUIDED PROGNOSTICATION OF TREATMENT RESPONSE
H. Minn (Finland)
15:20
SCREENING FOR DISTANT METASTASES IN HEAD AND NECK CANCER PATIENTS
BY FDG-PET(-CT) TO AVOID FUTILE TREATMENTS
R. de Bree (Netherlands), A. Senft, O. Hoekstra, D. J. Kuik, R. Golding, E. Comans, C.
R. Leemans
15:30
PET TO AVOID FUTILE LARYNGOSCOPIES IN PATIENTS WITH SUSPICION
OF RECURRENT LARYNGEAL CARCINOMA AFTER RADIOTHERAPY
R. de Bree, L. Van der Putten (Netherlands), O. Hoekstra, D. J. Kuik, E. Comans, C. R.
Leemans
15:40
ROLE OF 18F-FDG PET/TC IN THE PREDICTION OF RESPONSE TO NEOADJUVANT
CHEMOTHERAPY IN ADVANCED GASTRIC CANCER: OUR EXPERIENCE
F. Matteucci (Italy), A. Marzullo, A. Moretti, R. Galassi, F. Lio, A. Moro, P. Morgagni, G.
M. verdecchia
15:50
PRETREATMENT F-MISO HYPOXIC VOLUME IS PROGNOSTIC FOR LOCAL
CONTROL AFTER SINGLE DOSE IRRADIATION IN FADU HSCC
B. Beuthien-Baumann (Germany), C. Schütze, R. Bergmann, B. Mosch, A. Yaromina, K.
Brüchner, R. Greinke, F. Hessel, H. Thames, D. Zips, P. Mäding, M. Baumann
16.00
COFFEE BREAK
TARGET SELECTION / DELINEATION
16:30
SEGMENTATION, (AUTO) DELINEATION, 4D PET/CT
J. Nuyts (Belgium)
16:55
CLINICAL REQUIREMENTS FOR TARGET VOLUME SELECTION/
DELINEATION
U. Nestle (Germany)
17:20
USE OF GA-68-DOTATOC PET/CT FOR PLANNING THE STEREOTACTIC RT
IN SCULL BASE MENINGIOMAS
F. Nyuyki (Germany), R. Graf, D. Fahdt, R. Michel, L. Geworski, W. Brenner, M. Plotkin
17:30
FDG-PET GUIDED IMRT FOR PATIENTS WITH CERVICAL CANCER
P. Grigsby (USA)
17:40
IMPACT OF 18-FDG PET STAGING ON TREATMENT PLANNING IN RADIOTHERAPY
INCORPORATING ELECTIVE NODAL IRRADIATION FOR NONSMALL
CELL LUNG CANCER: PROSPECTIVE STUDY .
M. Kolodziejczyk (Poland), L. Kepka, M. Dziuk, A. Zawadzka, N. Szalus, A. Gizewska,
K. Bujko
17:50
FIRST RESULTS FROM LIST MODE BASED TARGET DELINEATION IN HIGH
PRECISION RADIOTHERAPY
I. Ernst (Germany), F. Buether, M. Dawood, P. Kraxner, C. Moustakis, M. Weckesser, O.
Schober, K. Schäfers, N. Willich, T. Boelling